These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 20717073)
1. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073 [TBL] [Abstract][Full Text] [Related]
3. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim Y; Kim DW; Lee JW; Min WS; Kim CC Bone Marrow Transplant; 2008 May; 41(9):813-20. PubMed ID: 18209725 [TBL] [Abstract][Full Text] [Related]
4. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286 [TBL] [Abstract][Full Text] [Related]
5. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063 [TBL] [Abstract][Full Text] [Related]
6. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555 [TBL] [Abstract][Full Text] [Related]
7. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559 [TBL] [Abstract][Full Text] [Related]
9. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange. Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787 [TBL] [Abstract][Full Text] [Related]
10. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770 [TBL] [Abstract][Full Text] [Related]
11. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC. de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309 [TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome. Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation. Lesesve JF; Alla F; Dugué F; Salignac S; Clément L; Lecompte T; Bordigoni P Int J Lab Hematol; 2011 Aug; 33(4):343-56. PubMed ID: 21284831 [TBL] [Abstract][Full Text] [Related]
15. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study. Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857 [TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced. Shimoni A; Yeshurun M; Hardan I; Avigdor A; Ben-Bassat I; Nagler A Biol Blood Marrow Transplant; 2004 Jul; 10(7):484-93. PubMed ID: 15205669 [TBL] [Abstract][Full Text] [Related]
20. Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause. Sala E; Neagoie AM; Lewerenz J; Saadati M; Benner A; Gantner A; Wais V; Döhner H; Bunjes D Transplant Cell Ther; 2024 Jun; 30(6):586.e1-586.e11. PubMed ID: 38508452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]